Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope ...

Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.

Although not listed as a hemorrhagic fever virus, illness caused by CHIKV ... A definitive diagnosis of Chikungunya infection can be made only with the aid of laboratory support since clinically ...

Zika virus hijacks the skin of its human host to send out chemical signals that lure more mosquitoes to infect and spread the ...

The world’s first chikungunya vaccine, developed by French pharmaceutical firm Valneva SE, has been approved in the UK by the ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...

Guillain-Barre Syndrome (GBS) is a serious illness that often progresses rapidly, making the patient bedridden in a few days ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

Researchers have uncovered how the dengue virus uses its envelope protein to hijack human plasmin to enhance transmission.